BR0212816A - Módulo de desativação de leucócito (lim) - Google Patents

Módulo de desativação de leucócito (lim)

Info

Publication number
BR0212816A
BR0212816A BR0212816-0A BR0212816A BR0212816A BR 0212816 A BR0212816 A BR 0212816A BR 0212816 A BR0212816 A BR 0212816A BR 0212816 A BR0212816 A BR 0212816A
Authority
BR
Brazil
Prior art keywords
leukocyte
lim
module
present
deactivation module
Prior art date
Application number
BR0212816-0A
Other languages
English (en)
Inventor
Scholz Martins
Original Assignee
Leukocare Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leukocare Gmbh filed Critical Leukocare Gmbh
Publication of BR0212816A publication Critical patent/BR0212816A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"MóDULO DE DESATIVAçãO DE LEUCóCITO (LIM)". A presente invenção prove um modulo para reduzir a atividade de leucócitos o qual compreende um suporte e um ligante que está unido ao suporte e é apropriado para interagir com um receptor de leucócito. Além disso, a presente invenção provê um processo para reduzir a atividade de leucócitos usando dito módulo. A vantagem da presente invenção é que após ligar os leucácitos ativados no módulo de desativação de leucócito (LIM) , o efeito prejudicial das células é inibido dentro de minutos.
BR0212816-0A 2001-09-27 2002-09-16 Módulo de desativação de leucócito (lim) BR0212816A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10147638A DE10147638B4 (de) 2001-09-27 2001-09-27 Leukozyten-Inaktivierungs-Modul (LIM)
PCT/DE2002/003466 WO2003031473A1 (de) 2001-09-27 2002-09-16 Leukozyten-inaktivierungs-modul (lim)

Publications (1)

Publication Number Publication Date
BR0212816A true BR0212816A (pt) 2004-10-05

Family

ID=7700470

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212816-0A BR0212816A (pt) 2001-09-27 2002-09-16 Módulo de desativação de leucócito (lim)

Country Status (15)

Country Link
US (2) US20040241171A1 (pt)
EP (1) EP1430085B1 (pt)
JP (1) JP5503826B2 (pt)
CN (1) CN100346822C (pt)
AT (1) ATE438661T1 (pt)
BR (1) BR0212816A (pt)
CA (1) CA2461900A1 (pt)
DE (4) DE20121877U1 (pt)
HU (1) HUP0401803A2 (pt)
MX (1) MXPA04002736A (pt)
NO (1) NO20041682L (pt)
PL (1) PL368596A1 (pt)
RU (1) RU2327490C2 (pt)
WO (1) WO2003031473A1 (pt)
ZA (1) ZA200402205B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20121877U1 (de) 2001-09-27 2003-09-18 LeukoCare GmbH, 85646 Neufarn Leukozyten-Inaktivierungs-Modul (LIM)
US20100306144A1 (en) * 2009-06-02 2010-12-02 Scholz Martin B System and method for classifying information
JP6773217B2 (ja) * 2017-04-28 2020-10-21 ヤマハ株式会社 受信装置及び信号伝送システム

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443955A (en) * 1989-01-27 1995-08-22 Australian Membrane And Biotechnology Research Institute Receptor membranes and ionophore gating
EP0478914B1 (en) * 1990-07-27 1996-05-22 Pall Corporation Leucocyte depleting filter device and method of use
US5639376A (en) * 1994-01-10 1997-06-17 Hemasure, Inc. Process for simultaneously removing leukocytes and methylene blue from plasma
WO1995018665A1 (en) * 1994-01-10 1995-07-13 Hemasure, Inc. Device and process for removing leukocytes and viral inactivating agents from blood
JPH08173528A (ja) * 1994-12-26 1996-07-09 Terumo Corp 血液処理システム
WO1997012632A1 (en) * 1995-10-05 1997-04-10 Tkb Associates Limited Partnership Methods for treatment of diseases associated with a deficiency of fas ligand activity
WO1997038707A1 (en) * 1996-04-17 1997-10-23 Cytotherapeutics, Inc. Method and device for delivery of apoptosis-inducing molecules
JPH1076004A (ja) * 1996-09-05 1998-03-24 Kanegafuchi Chem Ind Co Ltd 体液処理用吸着材及び体液処理用吸着器
WO1998046242A1 (en) * 1997-04-11 1998-10-22 Stanford University Treatment of cancer by the administration of fas ligand expressing non-tumorigenic cells
US6204055B1 (en) * 1999-04-12 2001-03-20 Isis Pharmaceuticals, Inc. Antisense inhibition of Fas mediated signaling
DK1126859T3 (da) * 1999-03-17 2006-08-28 Jimro Co Ltd Blodleukocyt-aferese til behandling af HIV
JP2001103977A (ja) * 1999-10-12 2001-04-17 National Institute Of Animal Health ブタＦａｓリガンドの構造遺伝子
US6797514B2 (en) * 2000-02-24 2004-09-28 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
DE20121877U1 (de) 2001-09-27 2003-09-18 LeukoCare GmbH, 85646 Neufarn Leukozyten-Inaktivierungs-Modul (LIM)

Also Published As

Publication number Publication date
US7850969B2 (en) 2010-12-14
HUP0401803A2 (hu) 2004-11-29
US20080292643A1 (en) 2008-11-27
DE20121877U1 (de) 2003-09-18
CN100346822C (zh) 2007-11-07
JP5503826B2 (ja) 2014-05-28
MXPA04002736A (es) 2005-09-08
PL368596A1 (en) 2005-04-04
EP1430085A1 (de) 2004-06-23
DE50213747D1 (de) 2009-09-17
NO20041682L (no) 2004-04-26
RU2327490C2 (ru) 2008-06-27
CA2461900A1 (en) 2003-04-17
CN1558915A (zh) 2004-12-29
EP1430085B1 (de) 2009-08-05
DE10294578D2 (de) 2004-08-26
ATE438661T1 (de) 2009-08-15
US20040241171A1 (en) 2004-12-02
WO2003031473A1 (de) 2003-04-17
JP2005507908A (ja) 2005-03-24
DE10147638B4 (de) 2004-05-27
ZA200402205B (en) 2004-08-16
DE10147638A1 (de) 2003-04-17
RU2004112762A (ru) 2005-04-20

Similar Documents

Publication Publication Date Title
BR0203650A (pt) Estentor de auto-articulação
CA2364241A1 (en) Saddle pad and method of making same
MY117805A (en) Resorcinol derivatives
WO2004036376A3 (en) Multi-modal operation of a medical device system
BR0109107A (pt) Usos terapêuticos de mediadores ppar
BRPI0416602A (pt) promotores da apoptose de n-acilsulfonamida
BR0206985A (pt) Anticorpos modificados e métodos de uso
BR1100808A (pt) Agentes de contraste usados em estudos de ultra-som empregado em diagnóstico que compreendem microesferas compostas de um gás ou um precursor de gás encapsulado num invólucro de proteìna, processo para a preparação de um agente de contraste, microesferas, e, dispersão aquosa de microesferas
ATE234092T1 (de) 2-alkylpyrrolidine
BR0015307A (pt) Composto, composição, composição farmacêutica, métodos para tratar um distúrbio que é criado pela ou é dependente da disponibilidade diminuìda de serotonina, norepinefrina ou dopamina, e para inibir a absorção de norepinefrina sináptica, de serotonina sináptica e de dopamina sináptica em um paciente em necessidade destas, e, conjunto
ATE423525T1 (de) Reflektorsystem zur positionsbestimmung
NO972211D0 (no) Sulfonamid-substituerte kromaner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende kromanene
AR004545A1 (es) Derivados de purin-6-ona, procedimientos para su preparacion, el uso de los mismos en la preparacion de medicamentos, medicamentos que los contieneny un procedimiento para preparar dichos medicamentos
DE60332749D1 (de) Flacher instrumentenhalter
BR0210013A (pt) Gel oftálmico de pirenzepina
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
BR0212816A (pt) Módulo de desativação de leucócito (lim)
TR200102742T2 (tr) Rezorsinol türevleri
FI962550A (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
EE200100079A (et) Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud rakkude ebaloomuliku proliferatsiooni raviks imetajate ajus
BR0212070A (pt) ácidos nucléicos e polipeptìdeos bv8 com atividade mitogênica
BR0305018A (pt) Células dendrìticas tolerogênicas e usos terapêuticos para as mesmas
IL132773A0 (en) Guanidinylation reagents
SI1037629T1 (en) Combination of a retinoic acid metabolism blocking agent and a tocophereol
BR9905892A (pt) Catalisador e processo para a oxicloração de etileno a 1,2-dicloroetano

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2167 DE 17/07/2012.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C07K 14/705; C12N 5/06; A61K 38/17.

Ipc: C12N 5/078 (2010.01)

Ipc: C12N 5/078 (2010.01)